General Range

DOXYTUNE-C

Fortune LabsPanchkula, Haryana

Price on request/100 · MOQ 100 boxes

DOXYTUNE-C Injection by Fortune Labs contains Doxycycline 100 mg per vial, a prescription tetracycline-class antibiotic supplied as sterile lyophilised powder for intravenous infusion, with Vitamin C indicated on the packaging. Doxycycline works by inhibiting bacterial protein synthesis through binding to the 30S ribosomal subunit. DOXYTUNE-C may be prescribed for selected respiratory, rickettsial and other bacterial infections caused by susceptible microorganisms when intravenous treatment is appropriate. The product is supplied in protective carton packaging with an injection vial and accompanying components. Preparation and administration must follow verified manufacturer instructions and be performed by trained healthcare professionals, considering bacterial susceptibility, pregnancy status, potential adverse effects, infusion compatibility and recommended treatment duration.

CategoryGeneral Range

Min. Order100 boxes

Supplied byFortune Labs

CertificationWHO-GMP, ISO

Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.

View Company

Specifications

Composition: Doxycycline for Injection USP (With Vitamin C)
Packaging Type: Injection Vial with Accompanying Ampoule/Components and Printed Carton Box
Packaging Size: 100 mg/Vial
Dosage Form: Sterile Lyophilised Powder for Injection
Treatment: May treat selected bacterial respiratory infections.
Shelf Life: 24 Months
Storage: Store below 30°C, protect from light & moisture
Certification: WHO-GMP, ISO

Company Info

Fortune LabsPanchkula, Haryana

View Full Profile

Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.

Key Details

• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.

Product Portfolio & Therapeutic Ranges

• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?